The 5th Maudsley Prescribing Guidelines International Conference:
Assuring evidence-based prescribing in mental illness – the expanding Maudsley Guideline series took place in London in April 2025.
The following speakers presented at the 2025 Conference:
Professor David Taylor : “An update on clozapine” and “Long-acting antipsychotics – first line treatment for schizophrenia“
Professor of Psychopharmacology, King’s College London
Director of Pharmacy and Pathology, South London and Maudsley NHS Foundation Trust
Dr Delia Bishara: “Anticholinergic action and dementia“
Consultant Pharmacist for Mental Health of Older Adults and Dementia
South London and Maudsley NHS Foundation Trust
Shubhra Mace: “Prescribing in pregnancy and breast feeding“
Senior Pharmacist, South London and Maudsley NHS Foundation Trust
Clinical Care and Professional Lead, South East London Integrated Care System
Honorary Senior Lecturer, King’s College London
Professor Thomas Barnes: “Akathisia – history, measurement, relevance in modern psychiatry”
Professor Emeritus of Clinical Psychiatry
Imperial College London
Dr Siobhan Gee: “Treating mental illness in the context of physical disease “
Deputy Director of Pharmacy and Consultant Pharmacist for Liaison Psychiatry, South London and the Maudsley NHS Foundation Trust
Clinical Director, Mind & Body programme King’s Health Partners
Dr Toby Pillinger: “Considering body and mind when treating people with serious mental illness: insights from the 2nd edition of the Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry“
Psychiatrist, South London and Maudsley NHS Foundation Trust
Clinical lecturer, King’s College London
Dr Nicola Kalk: “Advances in the treatment of opioid dependence “
Consultant Addiction Psychiatrist, Kings College Hospital Addiction Care Team
Adjunct Senior Lecturer in the Addictions Department of the IOPPN, King’s College London
Professor Allan Young: “Ketamine – formulations and indications “
Chair of Academic Psychiatry and Head of the Division of Psychiatry in the Department of Brain Sciences in the Faculty of Medicine
Imperial College London
Dr Mark Horowitz: “Stopping psychotropic drugs“
Clinical Research Fellow in Psychiatry, North East London NHS Foundation Trust
Visiting Lecturer in Psychopharmacology, King’s College London
Delegate feedback from 2025 Conference was overwhelmingly positive. Attendees reported that their primary motivations for attending were to hear keynote speakers. They wanted to learn about current research in psychiatry. Attendees were also eager to attend presentations directly relevant to their clinical or professional practice. These objectives were met, with 78% of respondents rating achievement of learning objectives as excellent and 22% as very good. Overall satisfaction mirrored this, with 78% rating the Conference as excellent and 22% as very good.
This was ‘the third of three conferences I had travelled to Europe from Australia for,’ commented one international delegate. They added, ‘It was by far the best. It was so good to hear clinicians who are experts present material in such a patient-centred and pragmatic way. I would love there to be some longer conferences of this standard and particularly around children.’
Professor David Taylor : “An update on clozapine“